Tag: FDA

Bausch, Clearside receive U.S. approval for eye injection

FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly(Reuters) – Bausch Health Companies Inc and Clearside Biomedical Inc said on Monday they received approval from the U.S. health regulator for their eye injection, giving patients access to a novel treatment

FDA authorizes Roche drug for severely ill COVID-19 patients

COVID vaccines and heart inflammation in young adults a ‘likely’ link: CDC panel Fox News medical contributor Dr. Janette Nesheiwat argues the condition is extremely rare and says vaccine benefits outweigh any potential side effects. The Food and Drug Administration granted emergency approval to Roche’s Actemra (tocilizumab) to boost outcomes among hospitalized COVID-19 patients receiving

FDA says do not drink ‘Real Water’ brand alkaline water

(HealthDay)—As an investigation into a hepatitis outbreak in Nevada associated with Real Water brand alkaline water continues, no one should drink, cook, serve, or sell the water, the U.S. Food and Drug Administration said Wednesday. As of April 26, there had been 11 probable cases and one suspected case of acute nonviral hepatitis in Nevada.

FDA Revokes Emergency Use of Solo Bamlanivimab for COVID

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) has granted Eli Lilly’s request to revoke emergency use authorization for the COVID-19 monoclonal antibody therapy bamlanivimab when used as a monotherapy, saying the evidence indicates that it is likely not effective against currently circulating

FDA authorizes first T cell-based test to detect prior SARS-CoV-2

(HealthDay)—The T-Detect COVID Test, a T cell-based test that helps to identify individuals with recent or prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, was granted emergency use authorization, the U.S. Food and Drug Administration announced Friday. The next-generation sequencing-based test analyzes DNA sequences to identify those with an adaptive T cell immune response

Idorsia insomnia drug starts FDA review as founder Clozel's second act proceeds

FILE PHOTO: Jean-Paul Clozel, CEO of Swiss pharmaceutical company Idorsia, attends an interview with Reuters at the company’s headquarters in Allschwil near Basel, Switzerland May 15, 2018. Picture taken May 15, 2018. REUTERS/Arnd WiegmannZURICH (Reuters) – Idorsia’s insomnia drug was accepted for review by U.S. regulators, the Swiss drugmaker said on Wednesday, as founder Jean-Paul

FDA: S-ICD Generator Recall Due to Short Circuit Risk Is Class I

A company-initiated recall of two models of EMBLEM S-ICD (Boston Scientific) subcutaneous implantable cardioverter defibrillator pulse generators has been categorized as Class I by the US Food and Drug Administration (FDA), the agency announced today. The FDA notes that the advisory, which was communicated to patients and doctors in December, applies to 2825 of the

FDA approves Bristol-Myers' gene therapy for white blood cell cancer

(Reuters) – The U.S. Food and Drug Administration (FDA) on Friday approved Bristol-Myers Squibb’s cell-based gene therapy, Breyanzi, to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or have relapsed after, at least two other types of systemic treatment. The FDA granted approval of Breyanzi for the treatment

FDA authorizes marketing of ACL implant

(HealthDay)—An anterior cruciate ligament (ACL) implant that offers an alternative to traditional ACL reconstruction has received marketing authorization from the U.S. Food and Drug Administration—the first approval for an ACL tear treatment in more than 30 years, the agency announced yesterday. The Bridge-Enhanced ACL Repair (BEAR) Implant received approval under the De Novo premarket review

FDA ‘rapidly working to finalize’ Pfizer coronavirus vaccine approval

Fox News Flash top headlines for December 11 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. The U.S. Food and Drug Administration (FDA) is working toward quickly finalizing and issuing emergency approval for Pfizer and BioNTech’s coronavirus vaccine candidate, according to top FDA officials. “Following yesterday’s positive advisory committee meeting outcome regarding the

FDA warns of dangerous, bogus claims that bleach can treat COVID-19

(HealthDay)—A warning letter has been sent to a company marketing bogus and dangerous chlorine dioxide products for the prevention and treatment of COVID-19, the U.S. Food and Drug Administration says. The fraudulent claims by the Genesis II Church of Health and Healing about its “Miracle Mineral Solution” products are especially concerning in relation to children,

Trump wrongly claims FDA drug is approved to treat coronavirus

Trump claims an anti-malaria drug is APPROVED to treat coronavirus – but is corrected by the FDA head who says it is still ‘experimental’ and will be studied in some American patients President Trump said in a Thursday press conference that the anti-malaria drug hydroxychloroquine had been FDA-approved to treat coronavirus patients  FDA Commissioner Stephen

Swallowable device to detect Barrett’s esophagus receives FDA 510(k) clearance

Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center developed the test for early detection of Barrett’s esophagus that offers promise for preventing deaths from esophageal adenocarcinoma. The test involves a novel swallowable balloon device that samples the esophagus and a DNA assay that detects Barrett’s esophagus and esophageal